NCT07341347

Brief Summary

The aim of this observational study is to evaluate retinal microvascular alterations in patients with thyroid-associated orbitopathy (TAO) using optical coherence tomography angiography (OCTA). The specific objectives are:

  • To assess the impact of extraocular muscle (EOM) enlargement on vessel density in the superficial and deep retinal capillary plexuses in patients with TAO.
  • To determine the effect of increased orbital fat volume on superficial and deep retinal vessel density in TAO.
  • To evaluate the relationship between disease activity, as measured by the Clinical Activity Score (CAS), and retinal microvascular density in patients with TAO.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 9, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 22, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 14, 2026

Completed
Last Updated

January 14, 2026

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 22, 2025

Last Update Submit

January 7, 2026

Conditions

Keywords

cross-sectional

Outcome Measures

Primary Outcomes (1)

  • Retinal vessel density (VD)

    Vessel density reflects the proportion of perfused vasculature within a defined retinal area and serves as a quantitative marker of retinal microcirculation. VD was evaluated separately in the superficial capillary plexus and the deep capillary plexus across the whole image as well as within the foveal, parafoveal, and perifoveal regions. Changes in vessel density were used to characterize microvascular alterations associated with thyroid-associated orbitopathy compared to healthy patients and to explore their relationship with disease activity and orbital structural parameters in TAO patients.

    Baseline

Study Arms (2)

Patients with TAO

The study cohort consisted of patients diagnosed with TAO of varying activity and duration. All subjects were Caucasian without other significant ocular comorbidities that could confound retinal microvascular measurements. Patients with TAO were classified based on MRI characteristics into three subgroups: fat-predominant, muscle-predominant, and mixed type.

Control group

Participants without TAO or other significant ocular comorbidities were included. All subjects were Caucasian and were age- and gender-matched to the TAO patient group.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with TED followed at Department of Ophthalmology, University Hospital Osijek, Department of Ophthalmology, Croatia.

You may qualify if:

  • adult patients (≥18 years) of both sexes with a confirmed diagnosis of TAO treated at University Hospital Osijek.

You may not qualify if:

  • anterior segment pathology (e.g., central keratopathy),
  • primary open- or closed-angle glaucoma,
  • posterior segment disorders (e.g., diabetic retinopathy, age-related macular degeneration, retinal vascular occlusion),
  • previous ocular trauma or uveitis,
  • refractive errors exceeding ±6.0 Diopter sphere or ±3.0 Diopter cylinder
  • media opacities that compromised angio optical OCTA image quality,
  • contraindication for orbital MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Osijek

Osijek, 31000, Croatia

Location

Related Publications (4)

  • Mihailovic N, Lahme L, Rosenberger F, Hirscheider M, Termuhlen J, Heiduschka P, Grenzebach U, Eter N, Alnawaiseh M. ALTERED RETINAL PERFUSION IN PATIENTS WITH INACTIVE GRAVES OPHTHALMOPATHY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Endocr Pract. 2020 Mar;26(3):312-317. doi: 10.4158/EP-2019-0328. Epub 2019 Dec 20.

    PMID: 31859550BACKGROUND
  • Yu L, Jiao Q, Cheng Y, Zhu Y, Lin Z, Shen X. Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography. BMC Ophthalmol. 2020 Oct 20;20(1):421. doi: 10.1186/s12886-020-01692-7.

    PMID: 33081749BACKGROUND
  • Ye L, Zhou SS, Yang WL, Bao J, Jiang N, Min YL, Yuan Q, Tan G, Shen M, Shao Y. RETINAL MICROVASCULATURE ALTERATION IN ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY. Endocr Pract. 2018 Jul;24(7):658-667. doi: 10.4158/EP-2017-0229.

    PMID: 30048168BACKGROUND
  • Wu H, Song Q, Zhang Y, Cheng R, Li Y, Su M, Zhang X, Sun X. Optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) for assessing thyroid-associated ophthalmopathy activity. Photodiagnosis Photodyn Ther. 2025 Jun;53:104578. doi: 10.1016/j.pdpdt.2025.104578. Epub 2025 Apr 3.

    PMID: 40187512BACKGROUND

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2025

First Posted

January 14, 2026

Study Start

December 9, 2024

Primary Completion

June 15, 2025

Study Completion

July 30, 2025

Last Updated

January 14, 2026

Record last verified: 2025-12

Locations